New patent for Strongbridge drug RECORLEV

November 4, 2022 Comments Off Posted in: Patent Added

Annual Drug Patent Expirations for RECORLEV Recorlev is a drug marketed by Strongbridge and is included in one NDA. There are six patents protecting this drug. This drug has twenty-eight…

The post New patent for Strongbridge drug RECORLEV appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.